Based on Pathfinder™ core-engine software IMSTAR-DX solutions. All its modules software derived from it and benefit from basic features some of which are patented and owners.
Robust and strong this important base
of development technological, it is the basis of a solution innovative and mature.
A blood test based on a unique marker allowing to discriminate between a benign tumor and an early stage cancer with 94% of sensitivity
Accessible, affordable to all Pathology and Biology labs, biopharmaceuticals, clinical research organizations, and university hospitals
Viewer for Virtual slide with perfect focus on all the scanned tissue or cytology sam
Operator independent tumour markers thanks to validated, specific markers software module
Provide Augmented Intelligence & Machine-Learning technologies to change the way the cancer is detected and characterized.
Our mission is to perfect cancer in-vitro diagnosis by combining 25 years of experience in: Cell recognition & characterization, markers quantification embedded in Pathfinder™ proprietary technology, offering automated solutions for :